Ani Pharmaceuticals (ANIP) Short term Debt (2012 - 2026)
Ani Pharmaceuticals (ANIP) posted Short term Debt of $19.3 million for Q1 2026, up 11.76% sequentially from $17.3 million in Q4 2025, and up 72.41% YoY from $11.2 million in Q1 2025.
Ani Pharmaceuticals (ANIP) Short term Debt (2012 - 2026) Analysis & Trends
Ani Pharmaceuticals has reported Short term Debt for 11 years, with the latest figure at $19.3 million in Q1 2026.
- Quarterly Short term Debt rose 72.41% year-over-year to $19.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $19.3 million (up 72.41% YoY) and the FY2025 annual result came in at $17.3 million, up 88.27% from the prior year.
- Short term Debt rose to $19.3 million in Q1 2026 per ANIP's latest filing, from $17.3 million in the prior quarter.
- Over five years, Short term Debt peaked at $19.3 million in Q1 2026 and troughed at $414000.0 in Q1 2024.
- A 5-year average of $5.8 million and a median of $850000.0 in 2022 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2022 and 2025: Short term Debt plunged 94.66% in 2022, then jumped 2603.62% in 2025.
- Over 5 years, Short term Debt stood at $850000.0 in 2022, then surged by 1343.06% to $12.3 million in 2023, then slipped by 25.22% to $9.2 million in 2024, then jumped by 88.27% to $17.3 million in 2025, then grew by 11.76% to $19.3 million in 2026.
- According to Business Quant data, Short term Debt over the past three periods registered $19.3 million, $17.3 million, and $15.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Ani Pharmaceuticals | 1.63 Bn | 1.27 Bn | 165.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.33 Mn |
| Mar 31, 2026 | 19.30 Mn |
| Dec 31, 2025 | 17.27 Mn |
| Sep 30, 2025 | 15.24 Mn |
| Jun 30, 2025 | 483,000.00 |
| Mar 31, 2025 | 11.19 Mn |
| Dec 31, 2024 | 9.17 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 841,000.00 |
| Mar 31, 2024 | 414,000.00 |
| Dec 31, 2023 | 12.27 Mn |
| Sep 30, 2023 | 850,000.00 |
| Jun 30, 2023 | 850,000.00 |
| Mar 31, 2023 | 850,000.00 |
| Sep 30, 2022 | 850,000.00 |
| Jun 30, 2022 | 850,000.00 |
| Mar 31, 2022 | 850,000.00 |
| Dec 31, 2021 | 850,000.00 |
| Sep 30, 2021 | 15.93 Mn |
| Jun 30, 2021 | 15.18 Mn |